Teleflex Stock (NYSE:TFX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$133.99

52W Range

$100.18 - $139.67

50D Avg

$129.66

200D Avg

$120.15

Market Cap

$5.95B

Avg Vol (3M)

$746.26K

Beta

0.82

Div Yield

$1.36 (1.01%)

TFX Company Profile


Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

14,100

IPO Date

Mar 17, 1980

Website

TFX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Other$9.04M$207.22M$291.90M
Surgical$418.15M$450.48M$427.36M
Vascular Access$917.73M$732.67M$708.04M
Interventional$647.79M$586.06M$511.43M
Anesthesia-$395.29M$389.96M
Interventional Urology-$331.09M$319.79M

Fiscal year ends in Dec 25 | Currency in USD

TFX Financial Summary


Dec 25Dec 24Dec 23
Revenue$1.99B$3.05B$2.97B
Operating Income$58.53M$151.01M$506.31M
Net Income$-905.64M$69.67M$356.33M
EBITDA$302.51M$433.62M$761.21M
Basic EPS$-20.30$1.49$7.58
Diluted EPS$-20.25$1.48$7.53

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 07, 26 | 12:00 AM
Q4 25Feb 26, 26 | 8:00 AM
Q3 25Nov 06, 25 | 8:00 AM

Peer Comparison


TickerCompany
KRYSKrystal Biotech, Inc.
ALKSAlkermes plc
PTCTPTC Therapeutics, Inc.
MMSIMerit Medical Systems, Inc.
ARWRArrowhead Pharmaceuticals, Inc.
CRSPCRISPR Therapeutics AG
BLCOBausch + Lomb Corporation
STVNStevanato Group S.p.A.
TGTXTG Therapeutics, Inc.
PCVXVaxcyte, Inc.